Evaluating imaging factors in neuroblastoma outcomes
Impact of Image-defined Risk Factors on the Outcome of Patients With Neuroblastoma: A Retrospective Study
This study looks at how certain imaging factors can help predict the surgery outcomes and complications for kids with neuroblastoma when they are first diagnosed.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | N/A to 18 Years |
| Sex | All |
| Sponsor | Assiut University Academic / other |
| Locations | 1 site (Assiut) |
| Trial ID | NCT02558244 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess Image-defined Risk Factors (IDRF) in pediatric patients diagnosed with neuroblastoma at their initial presentation. By reviewing medical records from 2001 to 2015 at the South Egypt Cancer Institute, the study seeks to determine how these imaging factors can predict surgical outcomes and complications. The research will involve verifying pathologic diagnoses and analyzing imaging reports to identify the presence of IDRF, followed by tracking patient outcomes over time.
Who should consider this trial
Good fit: Ideal candidates for this study are children under 19 years old diagnosed with non-metastatic neuroblastoma.
Not a fit: Patients over 18 years old or those with metastatic neuroblastoma may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve surgical decision-making and outcomes for children with neuroblastoma.
How similar studies have performed: Previous studies have established the importance of IDRF in surgical planning for neuroblastoma, indicating a foundation for this research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients whose age less than 19 years. * Patients diagnosed with non-metastatic neruoblastoma. Exclusion Criteria: * Patients whose age more than 18 years.
Where this trial is running
Assiut
- Assiut University — Assiut, Egypt (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.